Proceedings of the Texas A&M Medical Student Grand Rounds

Genetic Variants of Complement Factor H and a High-Fat Diet are Associated with the Pathogenesis of Age-Related Macular Degeneration

July 16, 2019 Jasmine Nguyen

Jasmine Nguyen

Introduction. Age-related macular degeneration (AMD) is the leading cause of visual deficit in older populations in the developed world.1   There are two different types of AMD: a wet type and a dry type. The wet type is characterized by exudate with choroidal neovascularization while the dry type is characterized by the deposits of drusen within the retinal pigment epithelium (RPE).2 Both genetic and environmental factors play a role in the risk of developing AMD, however genetic factors play a larger role.3   Specifically smoking, higher dietary fat, and obesity play a larger role in the risk of developing AMD, while the Y402H variant of the CFH gene has also been supported to lead to a higher risk of AMD.1,3   Complement factor H (CFH) is involved in the inactivation of the alternate complement pathway.1 This high risk variant leads to chronic inflammation by inhibiting MP elimination during inflammation resolution that leads to vulnerability to uncontrolled complement activation.4   Furthermore this variant cannot inhibit the terminal complement pathway efficiently leading to more membrane attack complex in the choroid.5 Methods. Mice with either the wild genotype or the Y402H genotype were fed either a normal diet or a high fat, cholesterol enriched (HFC) diet and aged.1   In a separate experiment, mice with Cfh+/+, Cfh+/-, or Cfh -/- were either fed a normal diet or a HFC diet.2 The height of sub- RPE deposit was measured in each variation as well as RPE height itself.1,2   The presence of multinucleated cells was also measured to measure RPE damage.2 Results. It was found that the tallest deposits were found in mice with the Cfh +/- genotype fed a HFC diet and in mice with the Y402H genotypic variant.1,2 It is hypothesized that because Cfh -/- lacks the key activators of the complement cascade, it did not develop the pathology typical of AMD.1 Furthermore, in Cfh +/- mice, there is a much higher recruitment of mononuclear phagocytes (MNP), establishing a complement-mediated effector response in sub-RPE deposits present in comparison to Cfh -/- HFC mice.1   Conclusions. A deficiency in CFH or the high risk variant Y402H genotype is found to lead to a decrease in inactivation of the alternate complement pathway leading to a state of chronic inflammation due to decreased inactivation of the alternate complement cascade pathway that leads to the pathology characteristic of AMD when fed a HFC diet.1,5

  1. Landowski M, Kelly U, Klingeborn M, et al. Human complement factor H Y402H polymorphism causes an age- related macular degeneration phenotype and lipoprotein dysregulation in mice. Proc Natl Acad Sci U S A 2019;116(9):3703-3711. doi: 10.1073/pnas.1814014116 [doi].
  2. Toomey CB, Kelly U, Saban DR, Bowes Rickman C. Regulation of age-related macular degeneration-like pathology by complement factor H. Proc Natl Acad Sci U S A. 2015;112(23):3040. doi:10.1073/pnas.1424391112 [doi].
  3. Sobrin L, Seddon JM. Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Progress in Retinal and Eye Research. 2014;40:1-15. doi:10.1016/j.preteyeres.2013.12.004.
  4. Calippe B, Augustin S, Beguier F, et al. Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation. Immunity. 2017;46(2):261-272. doi:10.1016/j.immuni.2017.01.006.
  5. Whitmore SS, Sohn EH, Chirco KR, et al. Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy. Progress in Retinal and Eye Research. 2015;45:1-6 doi:10.1016/j.preteyeres.2014.11.005.
Neuroscience Nutrition
Previous Post

The Effects of Combined Drug Therapy in the Treatment of BRAF Mutated Melanoma

Next Post

The suppressive activities via FoxP3 demethylation in oral, epicutaneous, and sublingual peanut immunotherapies

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.